Pentoxifylline as an adjunct therapy in children with cerebral malaria

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Lell, Bertrand ^a,b,c   Köhler, Carsten ^c   Wamola, Betty ^a   Olola, Christopher Ho ^a   Kivaya, Esther ^a   Kokwaro, Gilbert ^a,d   Wypij, David ^e,f,g   Mithwani, Sadik ^a   Taylor, Terrie E ^h,i   Kremsner, Peter G ^b,c   Newton, Charles Rjc ^a,j,k  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b ALBERT SCHWEITZER HOSPITAL   (Gabon)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h MICHIGAN STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF MALAWI   (Malawi)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; MANNITOL; PARALDEHYDE; PENICILLIN G; PENTOXIFYLLINE; PHENOBARBITAL; PHENYTOIN; QUININE; TUMOR NECROSIS FACTOR; ANTIMALARIAL AGENT; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

AFRICA; AREA UNDER THE CURVE; ARTICLE; BACTERIAL MENINGITIS; BLOOD SAMPLING; BRAIN MALARIA; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; KENYA; MALE; MAXIMUM PLASMA CONCENTRATION; MORTALITY; PAPILLEDEMA; PILOT STUDY; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; SEIZURE; TIME TO MAXIMUM PLASMA CONCENTRATION; VITAL SIGN; BLOOD; CHEMISTRY; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; METHODOLOGY; PARASITEMIA; PARASITOLOGY; PATHOLOGY; PLASMA;

ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; KENYA; MALARIA, CEREBRAL; MALE; PARASITEMIA; PENTOXIFYLLINE; PLASMA; QUININE; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 78650272402     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-368     Document Type: Article

References (24)

1. Reduced microcirculatory flow in severe falciparum malaria: pathophysiology and electron-microscopic pathology. AM Dondorp E Pongponratn NJ White, Acta Trop 2004 89 309 317 10.1016/j.actatropica.2003.10.004 14744557
2. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. CR Newton S Krishna, Pharmacol Ther 1998 79 1 53 10.1016/S0163-7258(98)00008-4 9719344
3. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. A Ward SP Clissold, Drugs 1987 34 50 97 10.2165/00003495-198734010-00003 3308412 (Pubitemid 17092322)
4. Plasmodium falciparum: inhibition of erythrocyte rosette formation and detachment of rosettes by pentoxifylline. LG Lehman B Vu-Quoc J Carlson PG Kremsner, Trans R Soc Trop Med Hyg 1997 91 74 75 10.1016/S0035-9203(97)90402-8 9093634
5. Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline. G Stoltenburg-Didinger S Neifer U Bienzle WM Eling PG Kremsner, J Neurol Sci 1993 114 20 24 10.1016/0022-510X(93)90043-X 8433093
6. Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by pentoxifylline, and tumor necrosis factor secretion is reduced. J Prada C Prager S Neifer U Bienzle PG Kremsner, Infect Immun 1993 61 2737 2740 8500916
7. Pentoxifylline prevents murine cerebral malaria. PG Kremsner H Grundmann S Neifer K Sliwa G Sahlmüller B Hegenscheid U Bienzle, J Infect Dis 1991 164 605 608 1869848
8. Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. C Wenisch S Looareesuwan P Wilairatana B Parschalk S Vannapann V Wanaratana W Wernsdorfer W Graninger, Am J Trop Med Hyg 1998 58 343 347 9546416
9. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. G Di Perri IG Di Perri GB Monteiro S Bonora C Hennig M Cassatella R Micciolo S Vento S Dusi D Bassetti E Concia, J Infect Dis 1995 171 1317 1322 7751709
10. Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations. R Lauterbach D Pawlik B Tomaszczyk B Cholewa, Eur J Pediatr 1994 153 672 674 10.1007/BF02190690 7957428
11. Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults. BK Das S Mishra PK Padhi R Manish R Tripathy PK Sahoo B Ravindran, Trop Med Int Health 2003 8 680 684 10.1046/j.1365-3156.2003.01087.x 12869088
12. Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. S Looareesuwan P Wilairatana S Vannaphan V Wanaratana C Wenisch M Aikawa G Brittenham W Graninger WH Wernsdorfer, Am J Trop Med Hyg 1998 58 348 353 9546417 (Pubitemid 28160759)
13. Supportive pentoxifylline in falciparum malaria: no effect on tumour necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. CJ Hemmer G Hort CB Chiwakata R Seitz R Egbring W Gaus J Hogel M Hassemer PP Nawroth P Kern M Dietrich, Am J Trop Med Hyg 1997 56 397 403 9158047
14. The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya. JA Omumbo SI Hay CA Guerra RW Snow, Malar J 2004 3 17 10.1186/1475-2875-3-17 15202945
15. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. PA Winstanley EK Mberu WM Watkins SA Murphy B Lowe K Marsh, Trans R Soc Trop Med Hyg 1994 88 577 580 10.1016/0035-9203(94)90170-8 7992345
16. Management of seizures in children with falciparum malaria. BR Ogutu CR Newton, Trop Doct 2004 34 71 75 15117128
17. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. ME Molyneux TE Taylor JJ Wirima A Borgstein, Q J Med 1989 71 441 459 2690177
18. Estimation of areas. M Gibaldi D Perrier, Pharmacokinetics New York: Marcel Dekker 2 1982 445 449
19. Intracranial pressure in African children with cerebral malaria. CR Newton FJ Kirkham PA Winstanley G Pasvol N Peshu DA Warrell K Marsh, Lancet 1991 337 573 576 10.1016/0140-6736(91)91638-B 1671941
20. Management of severe malaria. DA Warrell, Parassitologia 1999 41 287 294 10697870
21. Cerebral malaria: optimising management. N Mturi CO Musumba BM Wamola BR Ogutu CR Newton, CNS Drugs 2003 17 153 165 10.2165/00023210-200317030-00002 12617695
22. Adjuvant therapy in cerebral malaria. S Mohanty DK Patel SS Pati SK Mishra, Indian J Med Res 2006 124 245 260 17085828
23. Kinetics of intravenous and oral pentoxifylline in healthy subjects. B Beermann R Ings J Mansby J Chamberlain A McDonald, Clin Pharmacol Ther 1985 37 25 28 10.1038/clpt.1985.6 3965236
24. The pharmacokinetics of oxpentifylline in man when administered by constant intravenous infusion. RM Ings F Nudemberg JL Burrows TA Bryce, Eur J Clin Pharmacol 1982 23 539 543 10.1007/BF00637503 7160423